Jeffrey Bartlett

The American company is focused on developing non-viral gene medicines for patients with genetically driven diseases. The company integrates capabilities from various scientific disciplines to create optimized therapeutics in a redosable, non-viral format. The company's proprietary development and delivery platforms are designed to achieve higher standards for potency, durability, redosability, and safety. Rampart Bioscience is committed to realizing the potential of gene therapy to provide safe, long-lasting treatments for a wide range of diseases. The company's culture is built on the tenets of authenticity, integrity, and personal freedom, and they are working together to achieve audacious goals. The company was founded by Louis Breton and Jeffrey Bartlett, and Louis Breton has been the CEO since incorporation.